159 related articles for article (PubMed ID: 36129616)
1. Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report.
Meimand SE; Azizi G; Yazdani R; Sanadgol N; Rezaei N
Immunol Res; 2023 Feb; 71(1):107-111. PubMed ID: 36129616
[TBL] [Abstract][Full Text] [Related]
2. [Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China].
Qiu ZQ; Lu CX; Wang W; Qiu JJ; Wei M
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):203-8. PubMed ID: 21575371
[TBL] [Abstract][Full Text] [Related]
3. [Gene mutations and clinical manifestations in children with glycogen storage disease type Ib].
Liang CL; Liu L; Sheng HY; Jiang MY; Yin X; Mei HF; Cheng J; Zhang W; Fan LP
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):661-5. PubMed ID: 23965881
[TBL] [Abstract][Full Text] [Related]
4. Glycogen storage disease type 1b: an early onset severe phenotype associated with a novel mutation (IVS4) in the glucose 6-phosphate translocase (SLC37A4) gene in a Turkish patient.
Oguz MM; Aykan E; Yilmaz G; Aytekin C; Karaer K; Açoğlu EA
Genet Couns; 2014; 25(4):389-94. PubMed ID: 25804016
[TBL] [Abstract][Full Text] [Related]
5. A novel SLC37A4 missense mutation in GSD-Ib without hepatomegaly causes enhanced leukocytes endoplasmic reticulum stress and apoptosis.
Xu Q; Tang H; Duan L; Zuo X; Shi X; Li Y; Zhao H; Zhang H
Mol Genet Genomic Med; 2021 Jan; 9(1):e1568. PubMed ID: 33280276
[TBL] [Abstract][Full Text] [Related]
6. Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib.
Sarajlija A; Djordjevic M; Kecman B; Skakic A; Pavlovic S; Pasic S; Stojiljkovic M
Eur J Med Genet; 2020 Mar; 63(3):103767. PubMed ID: 31536830
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 genome editing of SLC37A4 gene elucidates the role of molecular markers of endoplasmic reticulum stress and apoptosis in renal involvement in glycogen storage disease type Ib.
Skakic A; Andjelkovic M; Tosic N; Klaassen K; Djordjevic M; Pavlovic S; Stojiljkovic M
Gene; 2019 Jun; 703():17-25. PubMed ID: 30951856
[TBL] [Abstract][Full Text] [Related]
8. Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature.
Melis D; Fulceri R; Parenti G; Marcolongo P; Gatti R; Parini R; Riva E; Della Casa R; Zammarchi E; Andria G; Benedetti A
Eur J Pediatr; 2005 Aug; 164(8):501-8. PubMed ID: 15906092
[TBL] [Abstract][Full Text] [Related]
9. Three novel SLC37A4 variants in glycogen storage disease type 1b and a literature review.
Wang Z; Zhao R; Jia X; Li X; Ma L; Fu H
J Int Med Res; 2023 Dec; 51(12):3000605231216633. PubMed ID: 38087503
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants.
Skakic A; Djordjevic M; Sarajlija A; Klaassen K; Tosic N; Kecman B; Ugrin M; Spasovski V; Pavlovic S; Stojiljkovic M
Clin Genet; 2018 Feb; 93(2):350-355. PubMed ID: 28685844
[TBL] [Abstract][Full Text] [Related]
11. Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders.
Maiorana A; Tagliaferri F; Dionisi-Vici C
Front Endocrinol (Lausanne); 2023; 14():1145111. PubMed ID: 37152929
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology and gene therapy for glycogen storage disease type Ib.
Chou JY; Cho JH; Kim GY; Mansfield BC
J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of an inducible mouse model for glycogen storage disease type Ib.
Raggi F; Pissavino AL; Resaz R; Segalerba D; Puglisi A; Vanni C; Antonini F; Del Zotto G; Gamberucci A; Marcolongo P; Bosco MC; Grillo F; Mastracci L; Eva A
J Inherit Metab Dis; 2018 Nov; 41(6):1015-1025. PubMed ID: 29967951
[TBL] [Abstract][Full Text] [Related]
14. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration.
Kim GY; Lee YM; Kwon JH; Jun HS; Chou J
Biochem Biophys Res Commun; 2017 Jan; 482(4):569-574. PubMed ID: 27864142
[TBL] [Abstract][Full Text] [Related]
15. Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib.
Choi R; Park HD; Ko JM; Lee J; Lee DH; Hong SJ; Ki CS; Lee SY; Kim JW; Song J; Choe YH
Ann Lab Med; 2017 May; 37(3):261-266. PubMed ID: 28224773
[TBL] [Abstract][Full Text] [Related]
16. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Chou JY; Jun HS; Mansfield BC
J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
[TBL] [Abstract][Full Text] [Related]
17. A patient with common glycogen storage disease type Ib mutations without neutropenia or neutrophil dysfunction.
Martens DH; Kuijpers TW; Maianski NA; Rake JP; Smit GP; Visser G
J Inherit Metab Dis; 2006 Feb; 29(1):224-5. PubMed ID: 16601899
[TBL] [Abstract][Full Text] [Related]
18. DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia.
Dewulf JP; Chevalier N; Marie S; Veiga-da-Cunha M
Mol Genet Metab; 2023 Nov; 140(3):107712. PubMed ID: 38353183
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study.
Shao YX; Liang CL; Su YY; Lin YT; Lu ZK; Lin RZ; Zhou ZZ; Zeng CH; Tao CY; Liu ZC; Zhang W; Liu L
Orphanet J Rare Dis; 2024 Apr; 19(1):155. PubMed ID: 38605407
[TBL] [Abstract][Full Text] [Related]
20. Glycogen storage disease type Ib: role of glucose-6-phosphate transporter in cell metabolism and function.
Sim SW; Weinstein DA; Lee YM; Jun HS
FEBS Lett; 2020 Jan; 594(1):3-18. PubMed ID: 31705665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
